Cold chain for cell & gene therapies
Specialized courier and logistics networks that manage the temperature-controlled, chain-of-identity transport of autologous and allogeneic cell and gene therapy products between collection, manufacturing and patient-administration sites, sold by dedicated advanced-therapy-logistics providers rather than the cryogenic hardware itself.
1 · What it gives
Cold chain for cell and gene therapies is the logistics service layer that moves a patient’s own cells (autologous) or a donor-derived product (allogeneic) between collection site, manufacturing facility and point of administration, distinct from the cryogenic tanks, freezers and shippers that provide the underlying equipment. For an autologous CAR-T therapy, the same physical unit that leaves a patient as a starting material must return to that same patient as a finished, temperature-critical product — a chain-of-identity requirement layered on top of the chain-of-custody every logistics network must maintain. A specialized courier manages the door-to-door itinerary, customs clearance for cross-border shipments, real-time temperature and location tracking, and contingency response if a flight is cancelled or a shipment is delayed, coordinating between the collection center, the manufacturing site (which may be on a different continent) and the treating hospital. This service layer sits downstream of the cryogenic hardware (EQP-066) and general biospecimen logistics (SVC-134) — it is specifically the advanced-therapy-focused courier and program-management capability, not the tanks and freezers themselves, and not general clinical-trial specimen transport.
The key directions of cold chain for cell and gene therapies are:
- Chain-of-identity courier networks: door-to-door logistics providers that track and preserve the one-to-one link between a patient’s starting material and the finished therapy product returned to that same patient.
- Advanced-therapy-specific program management: dedicated logistics coordination teams that manage the full itinerary across collection, manufacturing and administration sites, often spanning multiple countries and regulatory jurisdictions.
- Real-time temperature and location tracking: connected monitoring across every leg of the shipment, with proactive alerting and contingency response for flight delays or customs holds that could jeopardize product viability.
- Cross-border customs and regulatory clearance: specialized import/export handling for biological material, navigating country-specific requirements for temperature- sensitive, patient-specific therapeutic products.
Sectoral value chain#
[Patient/donor collection site] ──> [Chain-of-identity labeling & packaging]
│
(temperature-controlled courier network)
│
▼
[Patient administration site] <─── [Customs/regulatory clearance] <─── [Manufacturing facility]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Collection-site coordination | The logistics provider coordinates pickup timing and initial packaging at the apheresis or biopsy collection site. | In: collected patient/donor material. Out: chain-of-identity-labeled, temperature-packaged shipment. |
| Chain-of-identity tracking | Every shipment carries a unique identifier linking it to a specific patient, tracked end-to-end regardless of how many legs or handoffs the journey requires. | In: labeled shipment. Out: continuously tracked, identity-linked product. |
| Temperature-controlled transport | A specialized courier network manages door-to-door transport, using cryogenic or controlled-ambient packaging matched to the product’s stability profile. | In: identity-linked shipment. Out: temperature-validated product in transit. |
| Customs and regulatory clearance | Cross-border shipments require specialized import/export handling for temperature-sensitive, patient-specific biological material. | In: in-transit shipment. Out: customs-cleared shipment, regulatory documentation. |
| Contingency management | Real-time monitoring flags flight delays, customs holds or temperature excursions, triggering a pre-planned contingency response. | In: tracking data, excursion alerts. Out: corrective action, updated delivery plan. |
| Delivery and chain-of-custody documentation | The product reaches the manufacturing or administration site with a complete, auditable chain-of-custody and chain-of-identity record. | In: delivered product. Out: GMP-compliant delivery and identity record. |
Cross-cutting technologies of the sector:
- Chain-of-identity software platforms: dedicated tracking systems that link each physical shipment to a specific patient record across every handoff, distinct from general shipment tracking.
- Multi-modal temperature-controlled routing: logistics networks combine air, ground and cryogenic dry-vapor packaging to match each leg of the journey to the product’s stability window.
- Proactive contingency protocols: pre-established backup routing and courier redundancy for time- and temperature-critical shipments, reducing the risk that a single flight cancellation jeopardizes an irreplaceable patient-specific product.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1Collection-site coordinationThe logistics provider coordinates pickup timing and initial packaging at the apheresis or biopsy collection site, initiating the chain-of-identity record.
- 2Chain-of-identity labeling and packagingPackaging & fill-finishThe shipment is labeled with a unique identifier linking it to a specific patient and packaged to the temperature-stability requirement of the product.Who can do this step matched automatically30,000tons industrial scale“[Luzhou Pack: Sustainable Food Packaging Manufacturer”Ecoware India1,500 tons/“Our range of 135+ biodegradable and compostable products includes plates, bowls, cups, trays, takeaway containers and custom food packaging solutions trusted by restaurants, cafés, …”Hotpack Global United Arab Emirates“Founded in 1995, Hotpack is a recognized leader in the manufacturing and supply of food packaging products.”RWDC Industries Singaporeindustrial scale“2026-04-02 [A Major Step Forward in the Fight Against Microplastics — RWDC Industries is positioning itself as a leader in sustainable biopolymers, specifically Solon PHA, a fully …”
- 3Temperature-controlled transportA specialized courier network manages door-to-door transport, using cryogenic or controlled-ambient packaging matched to the product’s stability profile.
- 4Customs and regulatory clearanceRegulatory & certificationCross-border shipments undergo specialized import/export handling for temperature- sensitive, patient-specific biological material.Registration in Russia / EAEU: Regulation
- 5Contingency managementReal-time monitoring flags flight delays, customs holds or temperature excursions, triggering a pre-planned contingency response to protect product viability.
- 6Delivery and documentation
The product reaches the manufacturing or administration site with a complete, auditable chain-of-custody and chain-of-identity record, meeting 21 CFR Part 210/211 and EU GMP Annex 1 documentation requirements.
4 · Who delivers
Matched suppliers (matched automatically)
| Cryoport Systems | United States | Producer | active |
| Novartis | Switzerland | Producer | active |
| Lonza Group | Switzerland | Producer | active |
| AstraZeneca | United Kingdom | Producer | active |
| Kheiron Biotech | Argentina | Services / consulting | active |
| Minicircle | United States | Research / RTO | active |
| AGC Biologics | United States | Producer | active |
| PBS Biotech | United States | Equipment | active |
| Fresenius | Germany | Producer | active |
| Johnson & Johnson | United States | Producer | active |
| ANFT (Association of Nature & Forest Therapy) | United States | Services / consulting | active |
| Becton Dickinson | United States | Producer | active |
In the services and supply catalogue 2 · paid service
Cleanrooms & process utilities · Engineering, EPC & validation
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| World Courier | 🇺🇸 USA | CAR-T and cell/gene therapy logistics program | Dedicated advanced-therapy courier positioning; long-distance chain-of-identity transport | Commercial |
| Marken | 🇬🇧 UK | Advanced therapy logistics | Published cell/gene therapy logistics operations expertise; global network | Commercial |
| Fisher Clinical Services | 🇺🇸 USA | Sample and IP logistics for cell/gene therapy | Packaging, labeling and cold-chain coordination for global clinical programs | Commercial |
| Cavalier Logistics | 🇺🇸 USA | Turn-key cold chain, multi-temperature order handling | Biopharma logistics precision positioning | Commercial |
5 · Rules & route to market
United States
The US hosts the category’s leading advanced-therapy logistics providers, serving the world’s largest concentration of cell and gene therapy manufacturing and clinical administration sites.
advanced-therapy logistics network depth, chain-of-identity program management leadership#
- World Courier: positions itself specifically around chimeric antigen receptor (CAR-T) and other cell/gene therapy logistics, with dedicated program messaging around the zero-margin-for-error nature of moving these products across long distances.
- Cavalier Logistics: provides turn-key cold chain and multi-temperature order handling for biopharma logistics, with dedicated messaging around cold-chain and pharma-logistics precision.
- Fisher Clinical Services: manages complex sample and investigational-product logistics specifically in support of cell and gene therapy programs, including packaging, labeling and cold-chain coordination for global clinical programs.
European Union
The United Kingdom hosts a global leader in advanced-therapy logistics specifically, with deep specialization in the cell and gene therapy chain-of-identity and program-management capability the category requires.
advanced-therapy logistics specialization, global program-management leadership#
- Marken (UK): provides dedicated advanced-therapy logistics with published learning-center content specifically on cell and gene therapy logistics operations, positioning the company around the precision required for this therapy class rather than general pharma cold chain.
China
No China-headquartered advanced-therapy logistics provider was screened in this round; demand is driven by China’s expanding cell and gene therapy clinical and commercial base, currently served largely through the same global logistics networks operating in the US and EU.
import- and global-network-served market, domestic cell/gene therapy clinical build-out#
- Global network coverage: World Courier, Marken and other global advanced-therapy logistics providers maintain China operations serving domestic cell and gene therapy clinical trials and commercial distribution.
- Domestic cell/gene therapy build-out: China’s growing cell and gene therapy clinical and manufacturing base is the main demand driver for advanced-therapy logistics capacity, without a confirmed domestic chain-of-identity courier network identified in this screen.
- Screening note: this screen focused on US/EU-headquartered global networks, given their established China operations; a dedicated China-originated candidate was not probed in this round.
6 · Money: tenders & grants
| Grant | Circularity of seafood supply chain European Commission · EU | Sep 21, 2027 302 days |
| Grant | Enhancing ecodesign and circularity of construction products European Commission · EU | Sep 22, 2027 303 days |
| Grant | Innovative circular solutions for end-of-life footwear through collection, sorting and recycling European Commission · EU | Sep 22, 2027 303 days |
| Grant | Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU | Apr 8, 2027 136 days |
| Grant | Replacing hazardous substances in biocidal products European Commission · EU | Sep 22, 2027 303 days |
7 · Tech stack & innovations
The stack layers chain-of-identity tracking, multi-modal temperature-controlled routing and cross-border regulatory clearance on a common contingency-management backbone.
- Chain-of-identity tracking systems:
- Dedicated software links each physical shipment to a specific patient record across every handoff, a requirement distinct from general shipment tracking because an autologous product must return to the exact same patient it originated from.
- Tracking persists across collection, manufacturing and administration legs, often spanning multiple couriers, countries and regulatory jurisdictions.
- Multi-modal temperature-controlled routing:
- Logistics networks combine air, ground and cryogenic dry-vapor packaging to match each leg of the journey to the product’s stability window, switching modes as needed to preserve product integrity.
- Route planning accounts for customs-hold risk and flight-schedule reliability specifically for temperature- and time-critical patient-specific shipments.
- Proactive contingency protocols:
- Pre-established backup routing and courier redundancy reduce the risk that a single flight cancellation or customs delay jeopardizes an irreplaceable patient-specific product.
- Real-time alerting triggers a pre-planned response the moment a temperature or schedule deviation is detected, rather than after the shipment has already been compromised.
Sources 4 · 0 independent · 4 producer sites
Producers' own sites 4
- World courier producer checked 2026-05-05 · link not kept
- Marken producer checked 2026-05-18 · link not kept
- Cavalier logistics producer checked 2026-08-03 · link not kept
- Fisher clinical services producer checked 2026-05-18 · link not kept